Aardvark Therapeutics, Inc. Common Stock (AARD) — Defensive Interval Ratio
Aardvark Therapeutics, Inc. Common Stock (AARD) has a Defensive Interval Ratio of 2960 days as of September 2025. Defensive assets of $87.06 Million (cash $-, short-term investments $87.06 Million, receivables $-) cover 2960 days of daily cash needs of $29.41K/day. See Aardvark Therapeutics, Inc. Common Stock (AARD) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Aardvark Therapeutics, Inc. Common Stock Defensive Interval Ratio (2022–2024)
This chart shows how Aardvark Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the ratio stands at 2960 days, meaning defensive assets of $87.06 Million can fund 2960 days of operations without new revenue. See AARD net asset quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Aardvark Therapeutics, Inc. Common Stock (2022–2024)
The table below presents the year-by-year Defensive Interval Ratio for Aardvark Therapeutics, Inc. Common Stock from 2022 to 2024, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see AARD market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 891 days | $12.02 Million | $13.50K/day | $- | $12.02 Million | ▲ +824 days |
| 2023 | 67 days | $254.00K | $3.79K/day | $- | $254.00K | ▼ -268 days |
| 2022 | 335 days | $546.00K | $1.63K/day | $- | $546.00K | — |